Prot# AC-055G202: SERENADE - A Multi-center, Double-Blind, Placebo-Controlled Phase 2b Study to Evaluate the Efficacy and Safety of Macitentan in Subjects with Heart Failure with Preserved Ejection Fraction and Pulmonary Vascular Disease

Project: Research project

Project Details

StatusFinished
Effective start/end date11/13/17 → 11/13/21

Funding

  • Actelion Clinical Research, Inc. (Prot# AC-055G202)